PARIS, FRANCE, December 10, 2025 – Qynapse is present at the USPALZ 2025 Congress
Qynapse is participating in the USPALZ 2025 Congress to present its solutions dedicated to neurodegenerative diseases.
This presence reflects Qynapse’s mission to advance diagnostic precision and support clinical research in Alzheimer’s disease.